Accès ouvert · CC BY

Regulatory effects and potential therapeutic implications of alarin in depression, and arguments on its receptor

Article scientifique 2022 Sciences de la santé Anglais

Résumé

Alarin is a pleiotropic peptide involved in a multitude of putative biological activities, notably, it has a regulatory effect on depression-like behaviors. Although further elucidating research is needed, animal-based cumulative evidence has shown the antidepressant-like effects of alarin. In light of its regulatory role in depression, alarin could be used as a promising antidepressant in future treatment for depression. Nevertheless, the available information is still insufficient and the therapeutic relevance of alarin in depression is still of concern. Moreover, a plethora of studies have reported that the actions of alarin, including antidepressant activities, are mediated by a separate yet unidentified receptor, highlighting the need for more extensive research. This review focuses on the current understanding of the regulatory effects and future therapeutic relevance of alarin on depression, and the arguments on its receptors.

Citer ce document

Abebe, E. C., Mengstie, M. A., Seid, M. A., & Dejenie, T. A. (2022). Regulatory effects and potential therapeutic implications of alarin in depression, and arguments on its receptor. Frontiers in Psychiatry. https://doi.org/10.3389/fpsyt.2022.1051235

Exporter : BibTeX · RIS (Zotero, Mendeley, EndNote)

Accès au document

Texte intégral archivé sur SPHAERO, en accès ouvert : lisible gratuitement en ligne après connexion. Le document reste aussi disponible à sa source. Se connecter

Voir l'article sur le site de la revue

Licence et provenance

Licence : CC BY

Notice moissonnée depuis OpenAlex le 10/09/2026. Le document reste hébergé par sa source.
Voir le document à la source →

Statistiques

Consultations (hors robots) : 8

Téléchargements (hors robots) : 0

Méthode de comptage